January 13, 2018

MMJ Files Pre Investigational New Drug (IND) Application With FDA For Pharmaceutical THC -CBD derived medicine.

MMJ Files FDA application to initiate clinical trials assessing the company’s cannabinoid pharmaceutical compounds for treating and/or preventing symptoms associated with multiple sclerosis (MS) has been […]
//]]>